THE Pharmaceutical Society of Australia (PSA) is continuing its work as part of the Quality Use of Medicines (QUM) Alliance, a multidisciplinary group of health and consumer organisations delivering free health education for a national audience of health professionals and consumers.
The QUM Alliance, which includes the RACGP, the Black Dog Institute and HealthCare Consumers, is expanding into new topic areas including menopause, secondary stroke prevention, antidepressants in teens and young adults, osteoporosis and complex comorbidity.
These new topics build on the work of the QUM Alliance in atopic dermatitis (eczema), gout, antidepressants in older people, and oral anticoagulants in people with atrial fibrillation (PD 01 Apr).
PSA National President Associate Professor Fei Sim said: "PSA is leading the way for QUM education, representing the pharmacy profession and working closely with other Alliance members to upskill not only pharmacists but also other health professionals and consumers.
"We look forward to continuing this important work over the next three years, and encourage pharmacists across all areas of practice to engage with the QUM Alliance resources," Associate Professor Sim concluded.
See the PSA's QUM resources HERE.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Apr 25
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Apr 25
